Reprogramming the T cell response to cancer by simultaneous, nanoparticle-mediated PD-L1 inhibition and immunogenic cell death.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/AD9DA385.svg?ark=w1%2F20260526%2FAD9DA385&value=id)](https://nobleid.org/work/w1/20260526/AD9DA385)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors